119 related articles for article (PubMed ID: 8738761)
1. Monitoring of 8-methoxypsoralen during extracorporeal photochemotherapy: evidence for a "first-dose" effect.
Jacolot A; Tod M; Heudes AM; Petitjean O; Laroche L
Ther Drug Monit; 1996 Jun; 18(3):234-9. PubMed ID: 8738761
[TBL] [Abstract][Full Text] [Related]
2. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
Shephard SE; Nestle FO; Panizzon R
Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual variations of 8-methoxypsoralen plasma levels.
Schäfer-Korting M; Korting HC
Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
[TBL] [Abstract][Full Text] [Related]
5. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers.
Ljunggren B; Carter DM; Albert J; Reid T
J Invest Dermatol; 1980 Jan; 74(1):59-62. PubMed ID: 7351495
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
[TBL] [Abstract][Full Text] [Related]
8. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.
Sakuntabhai A; Diffey BL; Farr PM
Br J Dermatol; 1995 Dec; 133(6):919-23. PubMed ID: 8547045
[TBL] [Abstract][Full Text] [Related]
9. Molecular aspects of extracorporeal photochemotherapy.
Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
[TBL] [Abstract][Full Text] [Related]
10. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
Wu TW; Cui R; Zhang BX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
[TBL] [Abstract][Full Text] [Related]
11. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
Ljunggren B; Bjellerup M; Carter DM
J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
[TBL] [Abstract][Full Text] [Related]
13. 8-MOP plasma levels in PUVA problem cases with psoriasis.
Wagner G; Hofmann C; Busch U; Schmid J; Plewig G
Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594
[TBL] [Abstract][Full Text] [Related]
14. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
Shephard SE; Zogg M; Burg G; Panizzon RG
Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma.
Vielhauer S; Rudolphi A; Boos KS; Seidel D
J Chromatogr B Biomed Appl; 1995 Apr; 666(2):315-22. PubMed ID: 7633608
[TBL] [Abstract][Full Text] [Related]
16. Parenteral administration of 8-methoxypsoralen in photopheresis.
Knobler RM; Trautinger F; Graninger W; Macheiner W; Gruenwald C; Neumann R; Ramer W
J Am Acad Dermatol; 1993 Apr; 28(4):580-4. PubMed ID: 8463458
[TBL] [Abstract][Full Text] [Related]
17. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
[TBL] [Abstract][Full Text] [Related]
18. A method for the quantification of 8-methoxypsoralen by mass spectrometry for offline extracorporeal photopheresis.
Hähnel V; Dormann F; Nitsopoulos A; Friedle A; Ahrens N
Photochem Photobiol Sci; 2017 Feb; 16(2):193-200. PubMed ID: 27976780
[TBL] [Abstract][Full Text] [Related]
19. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
20. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
